Titre : Culture virale

Culture virale : Questions médicales fréquentes

Termes MeSH sélectionnés :

Ferric Compounds
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Culture virale : Questions médicales les plus fréquentes", "headline": "Culture virale : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Culture virale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-13", "dateModified": "2025-03-08", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Culture virale" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Techniques microbiologiques", "url": "https://questionsmedicales.fr/mesh/D008828", "about": { "@type": "MedicalCondition", "name": "Techniques microbiologiques", "code": { "@type": "MedicalCode", "code": "D008828", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E05.200.875" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Méthode des plages virales", "alternateName": "Viral Plaque Assay", "url": "https://questionsmedicales.fr/mesh/D010948", "about": { "@type": "MedicalCondition", "name": "Méthode des plages virales", "code": { "@type": "MedicalCode", "code": "D010948", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E05.200.875.970.790" } } } ], "about": { "@type": "MedicalCondition", "name": "Culture virale", "alternateName": "Virus Cultivation", "code": { "@type": "MedicalCode", "code": "D014776", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Arvind Varsani", "url": "https://questionsmedicales.fr/author/Arvind%20Varsani", "affiliation": { "@type": "Organization", "name": "2The Biodesign Center of Fundamental and Applied Microbiomics, School of Life Sciences, Center for Evolution and Medicine, Arizona State University, 1001 S. McAllister Ave, Tempe, AZ 85287-5001 USA." } }, { "@type": "Person", "name": "Giacomo Fais", "url": "https://questionsmedicales.fr/author/Giacomo%20Fais", "affiliation": { "@type": "Organization", "name": "Interdepartmental Centre of Environmental Science and Engineering (CINSA), University of Cagliari, Via San Giorgio 12, 09124 Cagliari, Italy." } }, { "@type": "Person", "name": "Mattia Casula", "url": "https://questionsmedicales.fr/author/Mattia%20Casula", "affiliation": { "@type": "Organization", "name": "Interdepartmental Centre of Environmental Science and Engineering (CINSA), University of Cagliari, Via San Giorgio 12, 09124 Cagliari, Italy." } }, { "@type": "Person", "name": "Pierluigi Caboni", "url": "https://questionsmedicales.fr/author/Pierluigi%20Caboni", "affiliation": { "@type": "Organization", "name": "Department of Life and Environmental Sciences, University of Cagliari, 09042 Cagliari, Italy." } }, { "@type": "Person", "name": "Giacomo Cao", "url": "https://questionsmedicales.fr/author/Giacomo%20Cao", "affiliation": { "@type": "Organization", "name": "Interdepartmental Centre of Environmental Science and Engineering (CINSA), University of Cagliari, Via San Giorgio 12, 09124 Cagliari, Italy." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Clinical, economical and safety impact of ferric carboxymaltose use in Patient Blood Management programme in Portuguese National Health Service hospitals.", "datePublished": "2022-11-11", "url": "https://questionsmedicales.fr/article/36369296", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-022-21929-3" } }, { "@type": "ScholarlyArticle", "name": "Effect of Ferric Carboxymaltose Supplementation in Patients with Heart Failure with Preserved Ejection Fraction: Role of Attenuated Oxidative Stress and Improved Endothelial Function.", "datePublished": "2022-11-28", "url": "https://questionsmedicales.fr/article/36501086", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/nu14235057" } }, { "@type": "ScholarlyArticle", "name": "Ferric derisomaltose for the treatment of iron deficiency anemia with postpartum hemorrhage: Results of a single-arm, open-label, phase 3 study in Japan.", "datePublished": "2023-01-18", "url": "https://questionsmedicales.fr/article/36653310", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/jog.15546" } }, { "@type": "ScholarlyArticle", "name": "Association between iron deficit repletion with ferric carboxymaltose relative to iron sucrose in children with inflammatory bowel disease: A retrospective cohort study.", "datePublished": "2023-06-12", "url": "https://questionsmedicales.fr/article/37199058", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/jpen.2515" } }, { "@type": "ScholarlyArticle", "name": "Clinical efficacy and safety of intravenous ferric carboxymaltose treatment for restless legs symptoms and low serum ferritin in children with autism spectrum disorder.", "datePublished": "2022-09-30", "url": "https://questionsmedicales.fr/article/36265207", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.sleep.2022.09.021" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Techniques d'investigation", "item": "https://questionsmedicales.fr/mesh/D008919" }, { "@type": "ListItem", "position": 3, "name": "Techniques de laboratoire clinique", "item": "https://questionsmedicales.fr/mesh/D019411" }, { "@type": "ListItem", "position": 4, "name": "Techniques microbiologiques", "item": "https://questionsmedicales.fr/mesh/D008828" }, { "@type": "ListItem", "position": 5, "name": "Culture virale", "item": "https://questionsmedicales.fr/mesh/D014776" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Culture virale - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Culture virale", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-15", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Culture virale", "description": "Comment se déroule un test de culture virale ?\nQuels échantillons sont utilisés pour la culture virale ?\nQuels tests complètent la culture virale ?\nCombien de temps prend une culture virale ?\nQuels signes indiquent une infection virale dans une culture ?", "url": "https://questionsmedicales.fr/mesh/D014776?mesh_terms=Ferric+Compounds&page=6#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Culture virale", "description": "Quels symptômes peuvent indiquer une infection virale ?\nLes symptômes varient selon le virus ?\nComment les symptômes évoluent-ils avec une infection virale ?\nLes symptômes sont-ils toujours présents lors d'une culture virale ?\nQuels symptômes nécessitent une culture virale urgente ?", "url": "https://questionsmedicales.fr/mesh/D014776?mesh_terms=Ferric+Compounds&page=6#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Culture virale", "description": "Comment prévenir les infections virales ?\nLes vaccins sont-ils efficaces contre tous les virus ?\nQuelles mesures d'hygiène sont recommandées ?\nLes masques aident-ils à prévenir les infections virales ?\nLes voyages augmentent-ils le risque d'infection virale ?", "url": "https://questionsmedicales.fr/mesh/D014776?mesh_terms=Ferric+Compounds&page=6#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Culture virale", "description": "Quels traitements sont disponibles pour les infections virales ?\nLa culture virale aide-t-elle à choisir un traitement ?\nLes antibiotiques sont-ils efficaces contre les virus ?\nComment les antiviraux agissent-ils ?\nLes traitements sont-ils les mêmes pour tous les virus ?", "url": "https://questionsmedicales.fr/mesh/D014776?mesh_terms=Ferric+Compounds&page=6#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Culture virale", "description": "Quelles complications peuvent survenir après une infection virale ?\nLes complications sont-elles prévisibles ?\nComment les complications sont-elles traitées ?\nLes enfants sont-ils plus à risque de complications ?\nLes personnes âgées sont-elles plus vulnérables aux complications ?", "url": "https://questionsmedicales.fr/mesh/D014776?mesh_terms=Ferric+Compounds&page=6#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Culture virale", "description": "Quels facteurs augmentent le risque d'infection virale ?\nL'âge influence-t-il le risque d'infection virale ?\nLes maladies chroniques augmentent-elles le risque ?\nLe mode de vie influence-t-il le risque d'infection virale ?\nLes voyages à l'étranger augmentent-ils le risque d'infection ?", "url": "https://questionsmedicales.fr/mesh/D014776?mesh_terms=Ferric+Compounds&page=6#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment se déroule un test de culture virale ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un échantillon est inoculé sur un milieu de culture pour observer la croissance virale." } }, { "@type": "Question", "name": "Quels échantillons sont utilisés pour la culture virale ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les échantillons peuvent inclure du sang, des sécrétions respiratoires ou des biopsies." } }, { "@type": "Question", "name": "Quels tests complètent la culture virale ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les tests sérologiques et PCR sont souvent utilisés pour confirmer l'infection virale." } }, { "@type": "Question", "name": "Combien de temps prend une culture virale ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "La culture virale peut prendre de quelques jours à plusieurs semaines selon le virus." } }, { "@type": "Question", "name": "Quels signes indiquent une infection virale dans une culture ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'apparition de cytopathies ou de plaques de lyse indique une infection virale." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer une infection virale ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, fatigue, toux, douleurs musculaires et éruptions cutanées sont fréquents." } }, { "@type": "Question", "name": "Les symptômes varient selon le virus ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, chaque virus peut provoquer des symptômes spécifiques selon son tropisme." } }, { "@type": "Question", "name": "Comment les symptômes évoluent-ils avec une infection virale ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent s'aggraver ou s'améliorer selon la réponse immunitaire." } }, { "@type": "Question", "name": "Les symptômes sont-ils toujours présents lors d'une culture virale ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Pas nécessairement, certains virus peuvent être asymptomatiques lors de la culture." } }, { "@type": "Question", "name": "Quels symptômes nécessitent une culture virale urgente ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes graves comme une détresse respiratoire ou une méningite justifient une culture." } }, { "@type": "Question", "name": "Comment prévenir les infections virales ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Vaccination, hygiène des mains et éviter le contact avec des personnes infectées." } }, { "@type": "Question", "name": "Les vaccins sont-ils efficaces contre tous les virus ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Non, chaque vaccin cible des virus spécifiques et leur efficacité varie." } }, { "@type": "Question", "name": "Quelles mesures d'hygiène sont recommandées ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Se laver les mains régulièrement et désinfecter les surfaces fréquemment touchées." } }, { "@type": "Question", "name": "Les masques aident-ils à prévenir les infections virales ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les masques réduisent la transmission des virus respiratoires." } }, { "@type": "Question", "name": "Les voyages augmentent-ils le risque d'infection virale ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les voyages peuvent exposer à de nouveaux virus et à des épidémies." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les infections virales ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les antiviraux, les immunoglobulines et les traitements symptomatiques sont utilisés." } }, { "@type": "Question", "name": "La culture virale aide-t-elle à choisir un traitement ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle permet d'identifier le virus et de déterminer la sensibilité aux antiviraux." } }, { "@type": "Question", "name": "Les antibiotiques sont-ils efficaces contre les virus ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Non, les antibiotiques ne sont efficaces que contre les infections bactériennes." } }, { "@type": "Question", "name": "Comment les antiviraux agissent-ils ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Ils inhibent la réplication virale ou modulent la réponse immunitaire." } }, { "@type": "Question", "name": "Les traitements sont-ils les mêmes pour tous les virus ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Non, chaque virus peut nécessiter un traitement spécifique selon sa biologie." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après une infection virale ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme la pneumonie, la méningite ou des syndromes post-viraux peuvent survenir." } }, { "@type": "Question", "name": "Les complications sont-elles prévisibles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être prévisibles selon le virus et l'état de santé du patient." } }, { "@type": "Question", "name": "Comment les complications sont-elles traitées ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement dépend de la complication, allant des soins de soutien à des interventions spécifiques." } }, { "@type": "Question", "name": "Les enfants sont-ils plus à risque de complications ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains virus peuvent entraîner des complications plus graves chez les enfants." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus vulnérables aux complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées ont un système immunitaire affaibli, augmentant le risque de complications." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque d'infection virale ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Un système immunitaire affaibli, le stress, et des conditions de vie insalubres augmentent le risque." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque d'infection virale ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les jeunes enfants et les personnes âgées sont plus susceptibles aux infections virales." } }, { "@type": "Question", "name": "Les maladies chroniques augmentent-elles le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme le diabète ou les maladies pulmonaires augmentent le risque d'infection." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque d'infection virale ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter le risque." } }, { "@type": "Question", "name": "Les voyages à l'étranger augmentent-ils le risque d'infection ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, voyager dans des zones endémiques expose à des virus non rencontrés localement." } } ] } ] }

Sources (10000 au total)

Effect of Ferric Carboxymaltose Supplementation in Patients with Heart Failure with Preserved Ejection Fraction: Role of Attenuated Oxidative Stress and Improved Endothelial Function.

Both clinical and experimental evidence shows that iron deficiency (ID) correlates with an increased incidence of heart failure (HF). Moreover, data on iron supplementation demonstrating a beneficial ...

Ferric derisomaltose for the treatment of iron deficiency anemia with postpartum hemorrhage: Results of a single-arm, open-label, phase 3 study in Japan.

Single-arm, open-label, phase 3 study to evaluate the efficacy and safety of ferric derisomaltose (FDI) for iron deficiency anemia (IDA) in Japanese women with postpartum hemorrhage (PPH).... Postpartum women aged 20-39 years with serum ferritin <25.0 ng/ml, hemoglobin (Hb) <10.0 g/dl, and blood loss ≥500 ml within 24 h post-delivery were eligible to receive high-dose intravenous FDI. The ... All (n = 21 [100.0%]) patients received the predetermined total iron dose by Day 8. Hb concentrations increased rapidly and significantly (p < 0.001) following FDI. Serum ferritin levels also increase... Rapid and sustained improvements in Hb and iron stores occurred following FDI for IDA with PPH, with no new safety signals identified.... JapicCTI-194888....

Association between iron deficit repletion with ferric carboxymaltose relative to iron sucrose in children with inflammatory bowel disease: A retrospective cohort study.

Iron deficiency and iron deficiency anemia are common in pediatric inflammatory bowel disease and often require supplementation with iron. There is a paucity of literature regarding optimal iron formu... This was a single-center retrospective study of pediatric patients with inflammatory bowel disease admitted for newly diagnosed disease or flare who received either iron sucrose or ferric carboxymalto... Thirty patients received ferric carboxymaltose. Sixty-nine patients received iron sucrose. Baseline hemoglobin and iron deficits were similar in both groups. A larger percentage of iron deficit was re... Hematologic and iron parameters responded more quickly with fewer infusions in patients who received ferric carboxymaltose vs iron sucrose. Patients who received ferric carboxymaltose achieved a highe...

Clinical efficacy and safety of intravenous ferric carboxymaltose treatment for restless legs symptoms and low serum ferritin in children with autism spectrum disorder.

Restless legs syndrome (RLS) may be underdiagnosed in children with autism spectrum disorder (ASD) due to difficulty expressing the symptoms in their own words. In addition, administration of oral iro... This was a retrospective, open-label case series of children with ASD, restless legs (RL) symptoms, and serum ferritin <30 μg/L, who either had failed or did not tolerate oral iron, and were subsequen... Nineteen children, 4-11 years old (12 male, median age 6, interquartile range (IQR 4-11) were included. A definite RLS diagnosis was identified in 6 verbal children (31.6%). RL symptoms (designated pr... The majority of children (84.2%) with ASD, restless legs symptoms, and serum ferritin <30 μg/L had clinical improvement and significantly better serum iron parameters after a single IV FCM infusion. A...

Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM-AHF trial.

In AFFIRM-AHF, intravenous ferric carboxymaltose (FCM) reduced heart failure (HF) hospitalisations and improved quality of life versus placebo in iron-deficient patients stabilised after an acute HF e... We included 1082 patients from AFFIRM-AHF: 590 with ischaemic HF (defined as investigator-reported ischaemic HF aetiology and/or prior acute myocardial infarction and/or prior coronary revascularisati... Heart failure hospitalisations and cardiovascular deaths occurred at a higher rate in patients with ishaemic versus those with non-ischaemic HF and were reduced by FCM versus placebo only in ischaemic...

Association Between Hemoglobin Levels and Efficacy of Intravenous Ferric Carboxymaltose in Patients With Acute Heart Failure and Iron Deficiency: An AFFIRM-AHF Subgroup Analysis.

Iron deficiency, with or without anemia, is an adverse prognostic factor in heart failure (HF). In AFFIRM-AHF (a randomized, double-blind placebo-controlled trial comparing the effect of intravenous f... AFFIRM-AHF was a multicenter, double-blind, randomized, placebo-controlled trial of FCM in hospitalized AHF patients with iron deficiency. Patients were stratified by baseline hemoglobin level (<12 ve... Of 1108 AFFIRM-AHF patients, 1107 were included in these subanalyses: 464 (FCM group, 228; placebo group, 236) had a hemoglobin level <12 g/dL, and 643 (FCM, 329; placebo, 314) had a hemoglobin level ... The effects of intravenous FCM on outcomes in iron-deficient patients stabilized after an AHF episode, including improvements in iron parameters over time, did not differ between patients with hemoglo... URL: https://www.... gov; Unique identifier: NCT02937454....

Tolerability of Oral Supplementation with Microencapsulated Ferric Saccharate Compared to Ferrous Sulphate in Healthy Premenopausal Woman: A Crossover, Randomized, Double-Blind Clinical Trial.

A single-center, crossover, randomized, double-blind, and controlled clinical study was conducted to assess the tolerability profile, especially with regard to gastrointestinal complaints, of oral sup...